Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.88 USD | -1.11% | +4.59% | -21.00% |
May. 23 | Transcript : Theravance Biopharma, Inc. - Special Call | |
May. 13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
Business Summary
Number of employees: 99
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Therapeutics
100.0
%
| 51 | 100.0 % | 57 | 100.0 % | +11.84% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
99.6
%
| 51 | 99.6 % | 57 | 99.6 % | +11.89% |
Europe
0.4
%
| 0 | 0.4 % | 0 | 0.4 % | +0.45% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 13-06-30 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 14-05-31 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 14-10-31 |
Richard Graham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rhonda Farnum
CTO | Chief Tech/Sci/R&D Officer | 59 | 18-06-30 |
Aine Miller
PRN | Corporate Officer/Principal | 47 | - |
Stacy Pryce
PRN | Corporate Officer/Principal | - | - |
Brett Grimaud
LAW | General Counsel | 50 | 21-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 14-05-31 |
Eran Broshy
BRD | Director/Board Member | 65 | 14-06-01 |
Director/Board Member | 59 | 20-06-30 | |
Susannah Gray
BRD | Director/Board Member | 63 | 23-02-25 |
Rick Winningham
CEO | Chief Executive Officer | 64 | 13-06-30 |
Jim Kelly
BRD | Director/Board Member | 43 | 23-04-10 |
Donal O'Connor
BRD | Director/Board Member | 73 | 15-10-20 |
Laurie Alsup
BRD | Director/Board Member | 70 | 18-02-12 |
Jeremy Grant
BRD | Director/Board Member | 36 | Dec. 20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,633,224 | 41,557,950 ( 85.45 %) | 0 | 85.45 % |
Company contact information
Theravance Biopharma, Inc.
901 Gateway Boulevard
94080, South San
+650 808 6000
http://www.theravance.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.00% | 437M | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- TBPH Stock
- Company Theravance Biopharma, Inc.